ArticleJournal of medicine and life2026
Healthcare costs of COVID-19 hospitalization in maintenance hemodialysis patients during the first two pandemic waves in Romania: a retrospective cohort study.
Article in Journal of medicine and life, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients receiving maintenance hemodialysis were highly vulnerable during the coronavirus disease 2019 pandemic because treatment continuity required repeated exposure to healthcare settings, while multiple comorbidities increased severe infection risk. Although many studies reported clinical outcomes in dialysis populations, fewer assessed hospitalization costs, particularly in Eastern Europe. This study evaluated hospitalization costs among maintenance hemodialysis patients admitted with COVID-19 during pandemic waves in Romania: Wave 1 (March-May 2020), Wave 2 (October 2020-February 2021), and Wave 3 (July-November 2021). We conducted a retrospective cohort study using linked administrative and clinical databases from a Romanian tertiary nephrology center. The source database included 126 entries. After exclusion of records lacking complete reimbursement or admission/discharge data, 84 hospitalization episodes were eligible for analysis. The dataset included the first two waves: 23 admissions in Wave 1 and 61 in Wave 2. Mean hospitalization cost increased from 6,216.51 RON in Wave 1 to 8,478.76 RON in Wave 2, while median cost increased from 3,094.44 RON to 5,281.90 RON. Mean length of stay decreased significantly from 18.39 to 11.61 days (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.